- Home
- BPMC vs MNSO Comparison
BPMC vs MNSO Comparison
Compare BPMC & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- MNSO
- Stock Information
- Founded
- BPMC 2008
- MNSO 2013
- Country
- BPMC United States
- MNSO China
- Employees
- BPMC N/A
- MNSO N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- MNSO Department/Specialty Retail Stores
- Sector
- BPMC Health Care
- MNSO Consumer Discretionary
- Exchange
- BPMC Nasdaq
- MNSO Nasdaq
- Market Cap
- BPMC 5.8B
- MNSO 6.5B
- IPO Year
- BPMC 2015
- MNSO 2020
- Fundamental
- Price
- BPMC $99.18
- MNSO $19.73
- Analyst Decision
- BPMC Buy
- MNSO Buy
- Analyst Count
- BPMC 21
- MNSO 4
- Target Price
- BPMC $124.05
- MNSO $24.40
- AVG Volume (30 Days)
- BPMC 1.0M
- MNSO 985.7K
- Earning Date
- BPMC 05-01-2025
- MNSO 05-16-2025
- Dividend Yield
- BPMC N/A
- MNSO 3.18%
- EPS Growth
- BPMC N/A
- MNSO 16.73
- EPS
- BPMC N/A
- MNSO 1.15
- Revenue
- BPMC $562,121,000.00
- MNSO $2,328,235,670.00
- Revenue This Year
- BPMC $44.85
- MNSO $25.91
- Revenue Next Year
- BPMC $32.06
- MNSO $18.77
- P/E Ratio
- BPMC N/A
- MNSO $15.35
- Revenue Growth
- BPMC 99.19
- MNSO 22.80
- 52 Week Low
- BPMC $73.04
- MNSO $12.51
- 52 Week High
- BPMC $121.90
- MNSO $27.71
- Technical
- Relative Strength Index (RSI)
- BPMC 65.95
- MNSO 63.00
- Support Level
- BPMC $97.91
- MNSO $17.52
- Resistance Level
- BPMC $104.86
- MNSO $18.83
- Average True Range (ATR)
- BPMC 3.74
- MNSO 0.58
- MACD
- BPMC 1.50
- MNSO 0.35
- Stochastic Oscillator
- BPMC 83.26
- MNSO 88.75
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.